Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuto Shibata

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Schizophrenia Bulletin|January 23, 2014
Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophreniaNarimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima, et al.
International Journal of Geriatric Psychiatry|December 11, 2014
Association between the catechol-O-methyltransferase polymorphism Val158Met and Alzheimer's disease in a Japanese populationNobuto Shibata, Tomoyuki Nagata, Kenji Tagai, et al.
Neuroscience Letters|May 29, 2003
Absence of association between Alzheimer disease and the regulatory region polymorphism of the PS2 gene in an Italian populationManuela Di Natale, Maria Perri, Toshitaka Kawarai, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 3, 2007
Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP)Hitoshi Maeshima, Tohru Ohnuma, Yoshie Sakai, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 9, 2016
Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophreniaRyoko Higashiyama, Tohru Ohnuma, Yuto Takebayashi, et al.
Neuromolecular Medicine|March 25, 2015
Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese PopulationEri Kawai, Nobuto Shibata, Tomoyuki Nagata, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 26, 2017
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophreniaShohei Nishimon, Tohru Ohnuma, Yuto Takebayashi, et al.
International Journal of Geriatric Psychiatry|October 5, 2016
Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control studyYoshihide Takeshita, Nobuto Shibata, Koji Kasanuki, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 12, 2016
Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese PopulationAyako Suzuki, Nobuto Shibata, Koji Kasanuki, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 11, 2012
No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophreniaMaiko Kitazawa, Tohru Ohnuma, Yuto Takebayashi, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Schizophrenia Bulletin|January 23, 2014
Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophreniaNarimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima, et al.
International Journal of Geriatric Psychiatry|December 11, 2014
Association between the catechol-O-methyltransferase polymorphism Val158Met and Alzheimer's disease in a Japanese populationNobuto Shibata, Tomoyuki Nagata, Kenji Tagai, et al.
Neuroscience Letters|May 29, 2003
Absence of association between Alzheimer disease and the regulatory region polymorphism of the PS2 gene in an Italian populationManuela Di Natale, Maria Perri, Toshitaka Kawarai, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 3, 2007
Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP)Hitoshi Maeshima, Tohru Ohnuma, Yoshie Sakai, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 9, 2016
Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophreniaRyoko Higashiyama, Tohru Ohnuma, Yuto Takebayashi, et al.
Neuromolecular Medicine|March 25, 2015
Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese PopulationEri Kawai, Nobuto Shibata, Tomoyuki Nagata, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 26, 2017
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophreniaShohei Nishimon, Tohru Ohnuma, Yuto Takebayashi, et al.
International Journal of Geriatric Psychiatry|October 5, 2016
Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control studyYoshihide Takeshita, Nobuto Shibata, Koji Kasanuki, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 12, 2016
Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese PopulationAyako Suzuki, Nobuto Shibata, Koji Kasanuki, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 11, 2012
No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophreniaMaiko Kitazawa, Tohru Ohnuma, Yuto Takebayashi, et al.
Pageof 9